SAN DIEGO, Calif. (Ivanhoe Newswire) - A breakthrough in bladder cancer treatment is helping to save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be ...

Shares of ImmunityBio IBRX were up 3% in after-market trading yesterday after the company announced that the FDA accepted its ...

Merck (MRK) shares rose nearly 5% in early trade on Friday after the company said a European medicines committee issued a ...

Detalimogene voraplasmid lead to numerous durable complete responses with favorable safety ...

Structured behavioral therapy focused on pelvic floor muscle exercise was noninferior to treatment with solifenacin for alleviating overactive bladder symptoms in patients with Parkinson’s disease (PD ...

When we think of smoking-related cancers, lung cancer usually comes to mind. But smoking is also a major driver for bladder cancer. Now, a new treatment has come to Philadelphia to help more patients ...

Advanced bladder cancer is particularly difficult to treat, with few options available to doctors. Often, the first line of treatment is chemotherapy with or without radiation. Treatments for advanced ...

A breakthrough in bladder cancer treatment is offering new hope to patients. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced new survey data highlighting the ...

A new study may pave the way toward more personalized treatments for patients with high-risk bladder cancer, according to a study published in European Urology.

You laugh at your best friend's joke-and feel a little leak. You sneeze in the grocery store and freeze. You skip the ...